92
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Clinical Characteristics of Young-Onset and Medical Treatment-Requiring Hypertension Identified By Targeted Screening in University Health Check-Up

, , , , , , , , & show all
Pages 552-557 | Received 15 Nov 2010, Accepted 26 Jan 2011, Published online: 29 Sep 2011

REFERENCES

  • Ejima Y, Hasegawa Y, Sanada S, . Characteristics of young-onset hypertension identified by targeted screening performed at a university health check-up. Hypertens Res 2006; 29:261–267.
  • Toyama H, Hasegawa Y, Ejima Y, . Characteristics of young-onset white coat hypertension identified by targeted screening for hypertension at a university health check-up. Hypertens Res 2008; 31:1063–1068.
  • Supino PG, Borer JS, Herrold EM, . Prognostic impact of systolic hypertension on asymptomatic patients with chronic severe aortic regurgitation and initially normal left ventricular performance at rest. Am J Cardiol 2005; 96:964–970.
  • Waller BF, Zoltick JM, Rosen JH, . Severe aortic regurgitation from systemic hypertension (without aortic dissection) requiring aortic valve replacement. Am J Cardiol 1982; 49:473–477.
  • Cuspidi C, Boselli L, Bragato R, . Echocardiographic and ultrasonographic evaluation of cardiac and vascular hypertrophy in patients with essential hypertension. Cardiology 1992; 80:305–311.
  • Couet J, Gaudreau M, Lachance D, . Treatment of combined aortic regurgitation and systemic hypertension: insights from an animal model study. Am J Hypertens 2006; 19:843–850.
  • Gardin JM, Constantine G, Davis K, Leung C, Reid CL. Aortic valvular regurgitation: prevalence and clinical characteristics in a predominantly obese adult population not taking anorexigens. Echocardiography 2006; 23:569–576.
  • Plante E, Lachance D, Gaudreau M, . Effectiveness of beta-blockade in experimental chronic aortic regurgitation. Circulation 2004; 110:1477–1483.
  • Sampat U, Varadarajan P, Turk R, Kamath A, Khandhar S, Pai RG. Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients. J Am Coll Cardiol 2009; 54:452–457.
  • Maurer G. Aortic regurgitation. Heart 2006; 92:994–1000.
  • Carabello BA, Crawford FA Jr. Valvular heart disease. N Engl J Med 1997; 337:32–41.
  • Rossi GP, Rossi E, Pavan E, . Screening for primary aldosteronism with a logistic multi-variate discriminant analysis. Clin Endocrinol (Oxford) 1998; 49:713–723.
  • Mulatero P, Dluhy RG, Giacchetti G, Boscaro M, Vegilio F, Stewart PM. Diagnosis of primary aldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab 2005; 16:114–119.
  • Rossi GP, Seccia TM, Pessina AC. Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension. Crit Rev Clin Lab Sci 2007; 44:1–85.
  • Goodfriend TL, Calhoun DA. Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 2004; 43:518–524.
  • Alvarez-Madrazo S, Padmanabhan S, Mayosi BM, . Familial and phenotypic associations of the aldosterone Renin ratio. J Clin Endocrinol Metab 2009; 94:4324–4333.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.